NovoCure: Q4 Earnings Snapshot

ST. HELIER, Jersey (AP) — ST. HELIER, Jersey (AP) — NovoCure Ltd. (NVCR) on Thursday reported a loss of $37.3 million in its fourth quarter.

The St. Helier, Jersey-based company said it had a loss of 36 cents per share.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 32 cents per share.

The oncology drug developer posted revenue of $128.4 million in the period, also falling short of Street forecasts. Five analysts surveyed by Zacks expected $128.6 million.

For the year, the company reported that its loss widened to $92.5 million, or 88 cents per share. Revenue was reported as $537.8 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on NVCR at

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up